Inhibition of the growth of transformed and neoplastic cells by the dipeptide carnosine

被引:70
作者
Holliday, R
McFarland, GA
机构
[1] CSIRO Division of Biomolecular Engineering, Sydney Laboratory, Sydney, NSW 2113
关键词
carnosine; pyruvate; HeLa cells; glycolysis; TCA cycle; non-enzymic glycosylation;
D O I
10.1038/bjc.1996.189
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human diploid fibroblasts grow normally in medium containing physiological concentrations of the naturally occurring dipeptide carnosine (beta-alanyl-L-histidine). These concentrations are cytotoxic to transformed and neoplastic cells lines in modified Eagle medium (MEM), whereas these cells grow vigorously in Dulbecco's modified Eagle medium (DMEM) containing carnosine. This difference is due to the presence of 1 mM sodium pyruvate in DMEM. Seven human cell lines and two rodent cell lines were tested and all are strongly inhibited by carnosine in the absence of pyruvate. Experiments with HeLa cells show that anserine is similar to carnosine, but D-carnosine and homocarnosine are without effect. Also, the non-essential amino acids alanine and glutamic acid contribute to the effect of pyruvate in preventing carnosine toxicity, and oxaloacetate and alpha-ketoglutarate can substitute for pyruvate. We have used mixtures of normal MRC-5 fibroblasts and HeLa cells to demonstrate that 20 mM carnosine can selectively eliminate the tumour cells. This has obvious implications which might be exploited in in vivo and in vitro studies. Carnosine is known to react strongly with aldehyde and keto groups of sugars by the Amadori reaction, and we propose that it depletes certain glycolysis intermediates. It is well known that tumour cells are more dependent on glycolysis than normal cells. A reduction of glycolysis intermediates by carnosine may deplete their energy supply, but this effect is totally reversed by pyruvate.
引用
收藏
页码:966 / 971
页数:6
相关论文
共 21 条
  • [1] AISENBERG AC, 1961, GLYCOLYSIS RESPIRATI
  • [2] DILLS WL, 1993, PARASITOLOGY, V107, P5177
  • [3] IN-VITRO CULTIVATION OF HUMAN TUMORS - ESTABLISHMENT OF CELL LINES DERIVED FROM A SERIES OF SOLID TUMORS
    GIARD, DJ
    AARONSON, SA
    TODARO, GJ
    ARNSTEIN, P
    KERSEY, JH
    DOSIK, H
    PARKS, WP
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1973, 51 (05) : 1417 - 1423
  • [4] NONENZYMATIC GLYCOSYLATION OF THE DIPEPTIDE L-CARNOSINE, A POTENTIAL ANTI-PROTEIN-CROSS-LINKING AGENT
    HIPKISS, AR
    MICHAELIS, J
    SYRRIS, P
    [J]. FEBS LETTERS, 1995, 371 (01) : 81 - 85
  • [5] CARNOSINE PROTECTS PROTEINS AGAINST IN-VITRO GLYCATION AND CROSS-LINKING
    HIPKISS, AR
    MICHAELIS, J
    SYRRIS, P
    KUMAR, S
    LAM, Y
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1994, 22 (04) : S399 - S399
  • [6] HUSCHTSCHA LI, 1983, J CELL SCI, V63, P77
  • [7] KAIGHN ME, 1979, INVEST UROL, V17, P16
  • [8] CARNOSINE AND ANSERINE CONCENTRATIONS IN THE QUADRICEPS FEMORIS MUSCLE OF HEALTHY HUMANS
    MANNION, AF
    JAKEMAN, PM
    DUNNETT, M
    HARRIS, RC
    WILLAN, PLT
    [J]. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY AND OCCUPATIONAL PHYSIOLOGY, 1992, 64 (01): : 47 - 50
  • [9] EVIDENCE FOR CLONAL ATTENUATION OF GROWTH POTENTIAL IN HELA-CELLS
    MARTINEZ, AO
    NORWOOD, TH
    PROTHERO, JW
    MARTIN, GM
    [J]. IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1978, 14 (12): : 996 - 1002
  • [10] RETARDATION OF THE SENESCENCE OF CULTURED HUMAN-DIPLOID FIBROBLASTS BY CARNOSINE
    MCFARLAND, GA
    HOLLIDAY, R
    [J]. EXPERIMENTAL CELL RESEARCH, 1994, 212 (02) : 167 - 175